RT @OmicsOmicsBlog: Now here’s a badass choice of a model system! #AGBT19 https://t.co/8Yp9pzDuOD
7:42pm March 1st 2019 via Hootsuite Inc.
Check out Perkin Elmer on Osprey 9 at #AGBT19 #tecmo bowl and #Pac-Man https://t.co/cvt4BwbrdW
6:11pm March 1st 2019 via Hootsuite Inc.
Badgett #AGBT19 Performance of Sequel II 8M new ZMW’s. https://t.co/wUWULwBVqm
3:49pm March 1st 2019 via Hootsuite Inc.
Ishii #AGBT19 Fragment distribution of size across samples https://t.co/TDLPfHKmBV
2:52pm March 1st 2019 via Hootsuite Inc.
Ishii #ABRF19 Illustration of methods - contrast to EM-Seq https://t.co/ZmW6E11QH8
2:45pm March 1st 2019 via Hootsuite Inc.
@00livier Yes the GeoMx from Nanostring is designed around FFPE. They have a service program now, system launches a… https://t.co/Owt2QqO1DC
2:42pm March 1st 2019 via Hootsuite Inc. in reply to 00livier
Mason #AGBT19 Rank on gene expression and epitope tag. Larger difference in expression of mRNA than protein. mRNA v… https://t.co/k1gl3wSsNa
2:37pm March 1st 2019 via Hootsuite Inc.
Blumenstiel #AGBT19 the drive to switch is in the right - 85% at 20x ‘with a lot less sequencing’ (about 50% less f… https://t.co/oNUk1ssiNW
1:20pm March 1st 2019 via Hootsuite Inc.
Blumenstiel #AGBT19 A fold-80 coverage plot showing penalty of coverage - lower is better. https://t.co/MMV8JaVIkk
1:18pm March 1st 2019 via Hootsuite Inc.
Lee #AGBT19 Evaluating performance of an exome - callability vs. total yield. https://t.co/3zsSAmHgLB
12:34pm March 1st 2019 via Hootsuite Inc.
RT @TwistBioscience: @EmilyLeproust touts our 15 min hybridization assay- allowing samples to be sequenced in a single day #AGBT19 #AGBT2019
12:24pm March 1st 2019 via Hootsuite Inc.
RT @nanostringtech: “With data demonstrating up to 60-plex protein assays and over 1,400 gene targets, the ability… https://t.co/huNEBWzvcr
12:05pm March 1st 2019 via Hootsuite Inc.
Charles #AGBT19 He was not in favor of this project. And then put in charge of it. Credits Graham Scott (former Lif… https://t.co/YkKqOXBkMz
9:57am March 1st 2019 via Hootsuite Inc.
Charles #AGBT19 Photo of the astronauts. https://t.co/anMddvZ5Ou
9:53am March 1st 2019 via Hootsuite Inc.
Charles #aaGBT19 Time to get to steady state. https://t.co/Ql8HYnTvfa
9:49am March 1st 2019 via Hootsuite Inc.
Charles #AGBT19 Risks values by duration. https://t.co/rHYxZg2eaf
9:36am March 1st 2019 via Hootsuite Inc.
RT @mason_lab: Dozens of enhancer-opathies known that influence or cause Mendelian diseases: a great list from Dr. Wendy Bickmore from @Edi…
9:22am March 1st 2019 via Hootsuite Inc.
RT @DCGenomics: Nothing in biology is as simple as we once thought! #agbt19 https://t.co/Uq5Lc2tTfq
RT @nanostringtech: Special thank you to @DaleYuzuki for attending our #SpatialGenomics Summit yesterday at #AGBT19… https://t.co/wefe3meG0P
6:15am March 1st 2019 via Hootsuite Inc.
RT @mason_lab: Aviv Regev showing the cool, emerging landscape and tool box for spatial genomics, including @nanostringtech GeoDx #AGBT19 h…
5:33am March 1st 2019 via Hootsuite Inc.
RT @mason_lab: @hagentilgner getting ~400GB on the new @PacBio 8M ZMW SMRTcell, with 1-5 million CCS cDNA reads and <1% error rate. Lower
5:32am March 1st 2019 via Hootsuite Inc.
RT @tysonaclark: Wow. Apparently I tweeted a lot in 2017. Don’t think I’ll make the list this year at #AGBT19. Go @DaleYuzuki. https://t…
5:02am March 1st 2019 via Hootsuite Inc.
Aganezov #AGBT19 photo if SV callers and inferences. https://t.co/kDtNyOx3cd
7:57pm February 28th 2019 via Hootsuite Inc.
Neafsey #AGBT19 Issue driven by the price of gold (!) and 'everyone is complicit'. Shows a gold toilet, and use as… https://t.co/9LcMSFa4OS
4:03pm February 28th 2019 via Hootsuite Inc.
Neafsey #AGBT19 Talks about Arteminsin resistance, worldwide distribution, evidence it is on the margin, and that r… https://t.co/MyprOYmYXW
4:00pm February 28th 2019 via Hootsuite Inc.
Daniel Neafsey (Harvard) #AGBT19 Rewinding the tape: Historical pathogen population genomics using selective genome… https://t.co/BmeJuZCIDk
3:56pm February 28th 2019 via Hootsuite Inc.
Chen #AGBt19 phot of the Centrellis Sema4 platform. Clinical test, Pt mgmt, Rx. https://t.co/3hCQ0I0Lil
11:37am February 28th 2019 via Hootsuite Inc.
Clark #AGBT19 The cost and batches diagram. https://t.co/CEXL3yHS7C
11:30am February 28th 2019 via Hootsuite Inc.
Clark #AGBT19 Comparison by GC content on GenapSys https://t.co/FQv0T10Gve
11:21am February 28th 2019 via Hootsuite Inc.
Costco #AGBT19 Photo of Readlength distribution and cumulative accuracy. https://t.co/lwvM5XTcLO
11:20am February 28th 2019 via Hootsuite Inc.
Clark #AGBT19 (With this slide I feel like I have heard the message of democratization before...) https://t.co/tTCdDk21iA
11:14am February 28th 2019 via Hootsuite Inc.
Regent #AGBT19 Summary of toolbox - and DNA microscopy on BioRxiv https://t.co/m9PbF0aGjF
9:32am February 28th 2019 via Hootsuite Inc.
Regent #AGBT19 Nice illustrationbof spatial methods available https://t.co/1oe4mwYXUL
9:25am February 28th 2019 via Hootsuite Inc.
Regent #AGBT19 interesting slide showing power of spatial information on cold vs hot niches in melanomas https://t.co/ULhwgdg25g
9:19am February 28th 2019 via Hootsuite Inc.
Good morning #AGBT19 - what a lot of fun at the reception last night! (Let the jealous glares begin for everybody e… https://t.co/GOLEc2pI0L
6:59am February 28th 2019 via Hootsuite Inc.
RT @antonioregalado: In upcoming test of Alzheimer's gene therapy, patients will be given "low risk" version of the… https://t.co/sqc1QGav0T
10:50pm February 27th 2019 via Hootsuite Inc.
RT @EricTopol: A masterful review of smartphones for infectious disease diagnoses and outbreaks… https://t.co/yu5npkUMuH
9:20pm February 27th 2019 via Hootsuite Inc.
Q: If a year earlier, does benefit take into account longer life? Cohen #AGBT19 Colonoscopy is definite benefit, other screening.
7:01pm February 27th 2019 via Hootsuite Inc.
Q: What if only protein alone is used? Cohen #AGBT19 Hard to directly answer - 50% sens. Clin test: much more stringent protein thresholds.
6:59pm February 27th 2019 via Hootsuite Inc.
Q: What's next? Cohen #AGBT19 Retrospective; now have ongoing clinical trial of 50K healthy individuals. Q: follow-… https://t.co/gzq0wZQIIy
6:58pm February 27th 2019 via Hootsuite Inc.
Cohen #AGBT19 Spec >99%, sensitivity is stage dependent (40% for Stg I, 70% for Stg II, 80% for Stg III). Detection… https://t.co/vsx16x1
6:54pm February 27th 2019 via Hootsuite Inc.
Cohen #AGBT19 Shows waterfall plots for the multi-analyte screening test. No individual marker is perfect. Used log… https://t.co/EpzihStGu0
6:52pm February 27th 2019 via Hootsuite Inc.
@h2so4hurts She did do a shoutout to the original BeadArray development team at #AGBT19 - man that brings back lots… https://t.co/DDTklUCcHO
6:50pm February 27th 2019 via Hootsuite Inc. in reply to h2so4hurts
Cohen #AGBT19 Uses Olivier Elemento's preprint chart https://t.co/TAA0NIjfDk illustrating the sampling problem. 66/… https://t.co/JC0xMojfr8
6:48pm February 27th 2019 via Hootsuite Inc.
Cohen #AGBT19 At 50-60 amplicons diminishing returns. Two multiplex reactions, total 61. 16 genes, 1933 distinct po… https://t.co/XtOSeRZ2Yn
6:47pm February 27th 2019 via Hootsuite Inc.
Cohen #AGBT19 Amplify - looking at PCR replicates as UID families. Balancing act - how many <80bp amplicons, what r… https://t.co/y8Ve0Fj
6:43pm February 27th 2019 via Hootsuite Inc.
Cohen #AGBT19 Safe-Sequencing system (Safe-SeqS) and explains method '11 PNAS https://t.co/9UQ2Osj2Zq Followup work… https://t.co/wNuF7VT3dj
6:40pm February 27th 2019 via Hootsuite Inc.
Cohen #AGBT19 Illustrates the need for dPCR to find that needle in a haystack; lays out the problem with error rate… https://t.co/7k0A4GP1nw
6:37pm February 27th 2019 via Hootsuite Inc.
Cohen #AGBT19 Starts with this impt slide - early detection is paramount. (Something I've been saying now at Single… https://t.co/HqqOgctr80
6:36pm February 27th 2019 via Hootsuite Inc.
Joshua Cohen (Johns Hopkins) #AGBT19 Detection and localization of surgically resectable cancers with a multi-analyte blood test
6:33pm February 27th 2019 via Hootsuite Inc.
